New hope for patients with untreatable solid tumors
Disease control
Recruiting now
This is the first study testing the experimental drug DPTX3186 in people with advanced solid tumors that have no other treatment options. The main goals are to check if the drug is safe and how the body processes it in about 40 participants. Researchers will also look for early s…
Phase: PHASE1 • Sponsor: Dewpoint Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC